Skip to content

VirogenX

Active Risk: not assessed
Private limited companyfounded 2026active for less than a yearJacobslaan 102, 2980 Zoersel, BelgiumKBO/BCE: BE 1036.186.662
Summary

VirogenX is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Overview

Activity
Research and development on biotechnology
NACE 72101
1 site
Size
No accounts filed yet
Financial health
No score: no figuresToo young for a bankruptcy probability
Structure
Signalsraises riskYoung companyShow the evidence

Signals

1 signal.
raises risk
raises risk · Young company
Founded in 2026, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years under a year 0 10 years
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2026.
KBO publications · our coverage
  1. IncorporationAppointment: DE JONGE Frederik (gewone…

Key points

  • Founded 6 months agofounded 30-03-2026 6 months View
  • No annual accounts yetat the National Bank 0 filed View
  • One director decidessole director in office 1 View

By topic

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
30-03-2026
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
19
Financial year
From 1 January to 31 December
Annual meeting
First Monday of May at 18:00
Purpose
“Het onderzoek, de ontwikkeling en de valorisatie van biotechnologische, farmaceutische en…” (deed in Dutch)
Statutory auditor
No statutory auditor
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.